Thomas Mayer (medical doctor)

from Wikipedia, the free encyclopedia
Thomas Mayer in summer 2018

Thomas Alexander Mayer (born June 20, 1959 in Rendsburg ) is a German neurologist , psychiatrist and epileptologist .

Life

Mayer studied human medicine from 1979 to 1985 in Marburg (1985 license to practice medicine and 1987 doctorate), Winterthur ( Switzerland ) and Siegen . He began his specialist training in neurology from 1986 to 1988 in Lüdenscheid , then continued it from 1988 to 1990 in the Mara Hospital ( Evangelical Clinic Bethel ) and finally from 1990 to 1991 in Berlin (recognized in 1992). He then worked from 1991 to 1992 in neurophysiology at the Physiological Institute of the University of Münster (with Erwin-Josef Speckmann ). At the same time, he completed his specialist training in psychiatry in the psychiatry department of the University of Münster by 1994.

From 1994 to 2003 Mayer was a senior physician at the Bethel Epilepsy Center, again at the Mara Hospital in Bielefeld (with Peter Wolf ).

Since 2003 he has been chief physician at the Saxon Epilepsy Center in Radeberg ("Kleinwachau") near Dresden , which was certified as a grade IV epilepsy center in 2007. Since 2009 he has also been the managing director of the Dresden Neurological Health Center (= Medical Care Center ). and since 2017 head of the Medical Center for Adults with Disabilities (MZEB) at the Saxon Epilepsy Center. Since 2011 he has been teaching clinical pharmacology at the International University of Dresden.

plant

After neurophysiological work from his time as an employee at the Physiological Institute of the University of Münster (e.g.), Mayer at the Epilepsy Center Bielefeld dealt with reflex attacks and epilepsy, among other things. Other scientific focal points were and are the problems of generics in epilepsy therapy, the value of new anti-epileptic drugs or participation in therapy guidelines of the German Society for Neurology.

In addition to (co-) authoring numerous articles in specialist journals and books, Mayer is (co-) author and (co-) editor of the following books and brochures:

  • T. Mayer, U. Specht, M. Schöndienst and others: Attack documentation. Instructions for observing, describing and documenting epileptic seizures. (founded by R. Dreyer, W. Wehmeyer). 4th, revised edition. von Bodelschwinghsche Anstalten, Bethel-Bielefeld 1997.
  • P. Wolf, T. Mayer, U. Specht et al. (Eds.): Praxisbuch Epilepsien. Diagnostics - treatment - rehabilitation. W. Kohlhammer, Stuttgart 2003.
  • C. Baumgartner, T. Grunwald , T. Mayer: The epileptological triathlon. Seizure Freedom - Side Effects - Social Freedom. Novartis Pharma, Nuremberg 2006.

Since 2002 Mayer has been chairman of the “Outpatient Epileptology” commission, since 2003 of the “Additional training in epileptology” commission, from 2010 to 2015 he was a member of the certification commission for epilepsy centers and from 2007 to 2019 he was the first managing director of the German Society for Epileptology (DGfE).

Web links

Individual evidence

  1. ↑ G. Krämer : Lexicon of Epileptology. Hippocampus Verlag, Bad Honnef 2012, p. 870.
  2. ↑ A. Lücke, T. Mayer, U. Altrup et al .: Simultaneous and continuous measurement of free concentration of valproate in blood and extracellular space of rat cerebral cortex. In: Epilepsia. 35, 1994, pp. 922-926.
  3. ↑ A. Lücke, U. Mußhoff, R. Köhling, M. Osterfeld, T. Mayer, P. Wolf, W. Schütte, EJ Speckmann: Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy. In: Br J Pharmacol. 124, 1998, pp. 370-376.
  4. ^ R. Köhling, K. König, A. Lücke, T. Mayer, P. Wolf, EJ Speckmann: Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices. In: Epilepsia. 43, 2002, pp. 1455-1461.
  5. ^ R. Köhling, K. König, A. Lücke, T. Mayer, P. Wolf, EJ Speckmann: Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices. In: Epilepsia. 43, 2002, pp. 1455-1461.
  6. ↑ T. Mayer, D. Giuccioli, J. Hoffmeister, P. Wolf: Retrospective study on 14 patients with startle epilepsy. In: P. Wolf (Ed.): Epilepsie 89. Einhorn-Presse Verlag, Reinbek 1989, pp. 93-98.
  7. ↑ T. Mayer, U. Specht: Propranolol in startle-induced seizures. In: J Neurol Neurosurg Psychiatry. 58, 1995, pp. 382-383.
  8. ^ P. Wolf, T. Mayer, M. Reker: Reading epilepsy: Report of five new cases and further considerations on the pathophysiology. In: Seizure. 7, 1998, pp. 271-279.
  9. ↑ T. Mayer, P. Wolf: Reading epilepsy: clinical and genetic background. In: S. Berkovic, P. Genton, C. Marescaux, F. Picard (Eds.): Genetics of Focal Epilepsies: Clinical Aspects and Molecular Biology. John Libbey & Company, London 1999, pp. 159-167.
  10. ↑ TA Mayer, F. Schroeder, TW May, PT Wolf: Perioral reflex myoclonias: a controlled study in patients with JME and focal epilepsies. In: Epilepsia. 47, 2006, pp. 1059-1067.
  11. ↑ T. Mayer, TW May, P. Wolf, DM Altenmüller: Clinical problems with generic antiepileptic drugs: comparison of two carbamazepine sustained-release formulations. In: Clin Pharmacokin / Clin Drug Investig. 18, 1999, pp. 17-26.
  12. ↑ U. Runge, S. Arnold, C. Brandt, F. Reinhardt, F. Kühn, K. Isensee, F. Ramirez, P. Dedeken, T. Lauterbach, M. Noack-Rink, T. Mayer: A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. In: Epilepsia. 56, 2015, pp. 1921-1930.
personal data
SURNAME Mayer, Thomas
ALTERNATIVE NAMES Mayer, Thomas Alexander (full name)
BRIEF DESCRIPTION German neurologist, psychiatrist and epileptologist
DATE OF BIRTH June 20, 1959
PLACE OF BIRTH Rendsburg